Advertisement

Topics

Sanofi, Regeneron to Make Praluent More Affordable for Patients with the Greatest Health Risk and Unmet Need​

11:41 EDT 14 Mar 2018 | Drug Discovery Development

A precision medicine approach will focus efforts on high-risk patients, such as those who have had heart attacks or unstable angina and cannot reduce their LDL-C below 100 mg/dL despite maximally-tolerated statins.
Contributed Author: 
Sanofi
Topics: 

Original Article: Sanofi, Regeneron to Make Praluent More Affordable for Patients with the Greatest Health Risk and Unmet Need​

NEXT ARTICLE

More From BioPortfolio on "Sanofi, Regeneron to Make Praluent More Affordable for Patients with the Greatest Health Risk and Unmet Need​"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...